$14.94
0.37[2.54%]
Last update: 12:27PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$15.24
0.3000[2.01%]
| Open14.785 | Close- |
| Vol / Avg.1.273K / 8.835K | Mkt Cap18.557M |
| Day Range14.380 - 15.090 | 52 Wk Range5.222 - 24.600 |
Acorda Therapeutics Stock (NASDAQ:ACOR), Key Statistics
Acorda Therapeutics Stock (NASDAQ: ACOR) analysis, key statistics.
Valuation Measures
Enterprise Value
174.3M
Trailing P/E
1.55
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.15
Price / Book (mrq)
0.27
Price / EBITDA
0.44
Enterprise Value / EBITDA (TTM)
4.24
Earnings Yield
64.72%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
54.64
Tangible Book value per share
-178.59
Total Liabilities (Quarterly)
296.8M
Total Assets
364.7M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
89.67%
Net Margin
-31.61%
EBIT Margin
-12.04%
EBITDA Margin
14.63%
Operating Margin
-15.02%
Acorda Therapeutics Stock (NASDAQ:ACOR), Key Statistics
Acorda Therapeutics Stock (NASDAQ: ACOR) analysis, key statistics.
Valuation Measures
Enterprise Value
174.3M
Trailing P/E
1.55
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.15
Price / Book (mrq)
0.27
Price / EBITDA
0.44
Enterprise Value / EBITDA (TTM)
4.24
Earnings Yield
64.72%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
54.64
Tangible Book value per share
-178.59
Total Liabilities (Quarterly)
296.8M
Total Assets
364.7M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
89.67%
Net Margin
-31.61%
EBIT Margin
-12.04%
EBITDA Margin
14.63%
Operating Margin
-15.02%
Acorda Therapeutics Stock (NASDAQ:ACOR), Key Statistics
Acorda Therapeutics Stock (NASDAQ: ACOR) analysis, key statistics.
Valuation Measures
Enterprise Value
174.3M
Trailing P/E
1.55
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.15
Price / Book (mrq)
0.27
Price / EBITDA
0.44
Enterprise Value / EBITDA (TTM)
4.24
Earnings Yield
64.72%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
54.64
Tangible Book value per share
-178.59
Total Liabilities (Quarterly)
296.8M
Total Assets
364.7M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
89.67%
Net Margin
-31.61%
EBIT Margin
-12.04%
EBITDA Margin
14.63%
Operating Margin
-15.02%
Acorda Therapeutics Stock (NASDAQ:ACOR), Key Statistics
Acorda Therapeutics Stock (NASDAQ: ACOR) analysis, key statistics.
Valuation Measures
Enterprise Value
174.3M
Trailing P/E
1.55
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.15
Price / Book (mrq)
0.27
Price / EBITDA
0.44
Enterprise Value / EBITDA (TTM)
4.24
Earnings Yield
64.72%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
54.64
Tangible Book value per share
-178.59
Total Liabilities (Quarterly)
296.8M
Total Assets
364.7M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
89.67%
Net Margin
-31.61%
EBIT Margin
-12.04%
EBITDA Margin
14.63%
Operating Margin
-15.02%
Acorda Therapeutics Stock (NASDAQ:ACOR), Key Statistics
Acorda Therapeutics Stock (NASDAQ: ACOR) analysis, key statistics.
Valuation Measures
Enterprise Value
174.3M
Trailing P/E
1.55
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.15
Price / Book (mrq)
0.27
Price / EBITDA
0.44
Enterprise Value / EBITDA (TTM)
4.24
Earnings Yield
64.72%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
54.64
Tangible Book value per share
-178.59
Total Liabilities (Quarterly)
296.8M
Total Assets
364.7M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
89.67%
Net Margin
-31.61%
EBIT Margin
-12.04%
EBITDA Margin
14.63%
Operating Margin
-15.02%
Acorda Therapeutics Stock (NASDAQ:ACOR), Key Statistics
Acorda Therapeutics Stock (NASDAQ: ACOR) analysis, key statistics.
Valuation Measures
Enterprise Value
174.3M
Trailing P/E
1.55
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.15
Price / Book (mrq)
0.27
Price / EBITDA
0.44
Enterprise Value / EBITDA (TTM)
4.24
Earnings Yield
64.72%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
54.64
Tangible Book value per share
-178.59
Total Liabilities (Quarterly)
296.8M
Total Assets
364.7M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
89.67%
Net Margin
-31.61%
EBIT Margin
-12.04%
EBITDA Margin
14.63%
Operating Margin
-15.02%
Acorda Therapeutics Stock (NASDAQ:ACOR), Key Statistics
Acorda Therapeutics Stock (NASDAQ: ACOR) analysis, key statistics.
Valuation Measures
Enterprise Value
174.3M
Trailing P/E
1.55
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.15
Price / Book (mrq)
0.27
Price / EBITDA
0.44
Enterprise Value / EBITDA (TTM)
4.24
Earnings Yield
64.72%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
54.64
Tangible Book value per share
-178.59
Total Liabilities (Quarterly)
296.8M
Total Assets
364.7M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
89.67%
Net Margin
-31.61%
EBIT Margin
-12.04%
EBITDA Margin
14.63%
Operating Margin
-15.02%
Acorda Therapeutics Stock (NASDAQ:ACOR), Key Statistics
Acorda Therapeutics Stock (NASDAQ: ACOR) analysis, key statistics.
Valuation Measures
Enterprise Value
174.3M
Trailing P/E
1.55
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.15
Price / Book (mrq)
0.27
Price / EBITDA
0.44
Enterprise Value / EBITDA (TTM)
4.24
Earnings Yield
64.72%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
54.64
Tangible Book value per share
-178.59
Total Liabilities (Quarterly)
296.8M
Total Assets
364.7M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
89.67%
Net Margin
-31.61%
EBIT Margin
-12.04%
EBITDA Margin
14.63%
Operating Margin
-15.02%
Acorda Therapeutics Stock (NASDAQ:ACOR), Key Statistics
Acorda Therapeutics Stock (NASDAQ: ACOR) analysis, key statistics.
Valuation Measures
Enterprise Value
174.3M
Trailing P/E
1.55
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.15
Price / Book (mrq)
0.27
Price / EBITDA
0.44
Enterprise Value / EBITDA (TTM)
4.24
Earnings Yield
64.72%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
54.64
Tangible Book value per share
-178.59
Total Liabilities (Quarterly)
296.8M
Total Assets
364.7M
Total Liabilities
- -
Profitability
Net income Growth
- -
Gross Margin
89.67%
Net Margin
-31.61%
EBIT Margin
-12.04%
EBITDA Margin
14.63%
Operating Margin
-15.02%